AGM/EGMApr 26, 2026, 05:29 AM
SRPT Announces 2026 Annual Meeting of Stockholders on June 4
AI Summary
Sarepta Therapeutics, Inc. filed a definitive proxy statement (DEF 14A) for its Annual Meeting of Stockholders to be held virtually on June 4, 2026. Stockholders will vote on the election of five Class I directors, an advisory resolution on named executive officer compensation, and the approval of the 2026 Equity Incentive Plan and 2026 Employee Stock Purchase Plan. Additionally, the ratification of KPMG LLP as the independent registered public accounting firm for the year ending December 31, 2026, is on the agenda. The Board of Directors recommends a vote FOR all proposals.
Key Highlights
- Annual Meeting of Stockholders to be held virtually on Thursday, June 4, 2026, at 10:00 A.M. EDT.
- Stockholders to elect five Class I directors: Douglas S. Ingram, Hans Wigzell, Kathryn J. Boor, Michael Chambers, and Deirdre Connelly.
- Advisory vote to approve named executive officer compensation.
- Approval of the Company's 2026 Equity Incentive Plan (2026 Plan).
- Approval of the Company's 2026 Employee Stock Purchase Plan (2026 ESPP).
- Ratification of KPMG LLP as the independent registered public accounting firm for 2026.
- Record date for voting eligibility is April 8, 2026.
- Board recommends a vote FOR all director nominees, executive compensation, 2026 Plan, 2026 ESPP, and auditor ratification.
Price Impact
More from SRPT